FR3261M - Médicament a base d'un α-méthyl-corticoide. - Google Patents

Médicament a base d'un α-méthyl-corticoide.

Info

Publication number
FR3261M
FR3261M FR967371A FR967371A FR3261M FR 3261 M FR3261 M FR 3261M FR 967371 A FR967371 A FR 967371A FR 967371 A FR967371 A FR 967371A FR 3261 M FR3261 M FR 3261M
Authority
FR
France
Prior art keywords
corticosteroid
methyl
product based
medicinal product
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR967371A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of FR3261M publication Critical patent/FR3261M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
FR967371A 1964-02-07 1964-03-13 Médicament a base d'un α-méthyl-corticoide. Expired FR3261M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESC034608 1964-02-07

Publications (1)

Publication Number Publication Date
FR3261M true FR3261M (fr) 1965-04-20

Family

ID=7433188

Family Applications (1)

Application Number Title Priority Date Filing Date
FR967371A Expired FR3261M (fr) 1964-02-07 1964-03-13 Médicament a base d'un α-méthyl-corticoide.

Country Status (1)

Country Link
FR (1) FR3261M (fr)

Similar Documents

Publication Publication Date Title
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
FR3111M (fr) Médicament a base de dérivé de cystéine.
FR3405M (fr) Médicament a base d'une sulfométhyl-polymyxine.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR3475M (fr) Médicament a base de diphényl-amino-éthylamine.
FR3668M (fr) Médicament a base d'hydrazines substitutées.
FR1827M (fr) Médicament a base de 1.5-benzo-dioxépannes.
FR2239M (fr) Médicaments a base de dialcoyl-aminoalcoyl-pipéridines.
FR3724M (fr) Médicament a base d'anisoyl-3 hydroxy-4 p. méthoxy-phényl-6α-pyrone.
FR3261M (fr) Médicament a base d'un α-méthyl-corticoide.
FR3323M (fr) Médicament a base de dérivé de l'aza-thiaxanthene.
FR3494M (fr) Médicament a base de 16α-méthyl-stéroides.
FR3565M (fr) Médicament a base d'un nonapeptide-amide cyclique.
FR3219M (fr) Médicament a base de n-alcoyl-n-alcoxy-β-phénylalcoylamines.
FR3272M (fr) Médicament a base d'hydrazines substituées.
FR2992M (fr) Médicament a base de 2.4-diamino-6-hydroxyméthyl-7.8-dihydro-ptéridine.
FR2877M (fr) Médicament a base d'amides.
FR3047M (fr) Médicament a base d'hexahydro-verrucarine a.
FR3774M (fr) Médicament a base de nouvelles oxaza-bicyclo-alcanones.
FR3757M (fr) Médicament a base de streptokinase.
FR3260M (fr) Médicament a base d'isopropanols.
FR2347M (fr) Médicament a base de sulfanilamides.
FR2093M (fr) Médicament a base de dérivé d'hydroxy-dibenzocycloheptane.
FR1144M (fr) Médicament a base de 1.2-diaryl-3.5-dioxo-pyrazolidines.